| P50 | author | Bernadette Biondi | Q86675029 |
| | Laszlo Hegedüs | Q89254124 |
| P2093 | author name string | George J Kahaly | |
| | Peter Laurberg | |
| | David S Cooper | |
| | Luigi Bartalena | |
| P2860 | cites work | Meta-analysis: Subclinical Thyroid Dysfunction and the Risk for Coronary Heart Disease and Mortality | Q22305331 |
| | 2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism | Q22306402 |
| | Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists | Q28236111 |
| | Subclinical thyroid disease: scientific review and guidelines for diagnosis and management | Q28238612 |
| | 2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation | Q28307011 |
| | Subclinical thyroid dysfunction and cognitive decline in old age | Q31114507 |
| | Subclinical thyroid dysfunction and mortality: an estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies | Q31157005 |
| | Thyroid function and left ventricular structure and function in the Framingham Heart Study | Q33538273 |
| | The Colorado thyroid disease prevalence study | Q33891706 |
| | Subclinical thyroid dysfunction and incident hip fracture in older adults | Q34004594 |
| | Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). | Q34113424 |
| | Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease | Q34182395 |
| | Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts | Q34347696 |
| | Clinical review: The thyroid in mind: cognitive function and low thyrotropin in older people | Q34367086 |
| | Duration of thyroid dysfunction correlates with all-cause mortality. the OPENTHYRO Register Cohort | Q34395450 |
| | 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society | Q34412804 |
| | Thyroid status, cardiovascular risk, and mortality in older adults | Q34421169 |
| | Subclinical thyroid dysfunction and fracture risk: a meta-analysis | Q34477885 |
| | Effects of thyroid hormone on cardiac function: the relative importance of heart rate, loading conditions, and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism | Q34559085 |
| | The clinical significance of subclinical thyroid dysfunction | Q34711990 |
| | Morbidity before and after the diagnosis of hyperthyroidism: a nationwide register-based study | Q34789638 |
| | Thyroid function in the euthyroid range and adverse outcomes in older adults | Q35096822 |
| | Hyperthyroidism, bone mineral, and fracture risk--a meta-analysis | Q35203965 |
| | Subclinical thyroid dysfunction and the risk for fractures: a systematic review and meta-analysis. | Q35492534 |
| | Effects of thyroid hormone on the cardiovascular system | Q35641813 |
| | Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trials | Q35675059 |
| | Antithyroid drugs | Q36061115 |
| | Subclinical hyperthyroidism: clinical features and treatment options | Q36068541 |
| | Thyroid diseases and cerebrovascular disease | Q36265366 |
| | Excess mortality in hyperthyroidism: the influence of preexisting comorbidity and genetic confounding: a danish nationwide register-based cohort study of twins and singletons | Q36361369 |
| | Solitary autonomously functioning thyroid nodules and iodine deficiency | Q71654266 |
| | Complex alteration of thyroid function in healthy centenarians | Q72165935 |
| | The clinical evaluation of patients with subclinical hyperthyroidism and free triiodothyronine (free T3) toxicosis | Q72355365 |
| | Bone mineral density in patients with endogenous subclinical hyperthyroidism: is this thyroid status a risk factor for osteoporosis? | Q72637022 |
| | Bone metabolism during anti-thyroid drug treatment of endogenous subclinical hyperthyroidism | Q72792412 |
| | Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism | Q73234395 |
| | Subclinical thyrotoxicosis | Q74420082 |
| | The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano survey | Q74449510 |
| | Normalization of serum thyrotrophin by means of radioiodine treatment in subclinical hyperthyroidism: effect on bone loss in postmenopausal women | Q74524375 |
| | TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays | Q74598699 |
| | Relationships existing between the serum cytokine levels and bone mineral density in women in the premenopausal period affected by Graves' disease with subclinical hyperthyroidism | Q75187358 |
| | Effect of endogenous subclinical hyperthyroidism on bone metabolism and bone mineral density in premenopausal women | Q78015063 |
| | Approach to the patient with subclinical hyperthyroidism | Q79512674 |
| | The relationship between serum TSH and bone mineral density in men and postmenopausal women: the Tromsø study | Q79619975 |
| | Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis | Q80159306 |
| | Association between serum free thyroxine concentration and atrial fibrillation | Q80336240 |
| | Favorable clinical heart and bone effects of anti-thyroid drug therapy in endogenous subclinical hyperthyroidism | Q80341543 |
| | Serum thyrotropin measurements in the community: five-year follow-up in a large network of primary care physicians | Q80656736 |
| | The natural history of subclinical hyperthyroidism in patients below the age of 65 years | Q81095860 |
| | Subclinical thyrotoxicosis in an outpatient population - predictors of outcome | Q82277919 |
| | Prospective echocardiographic evaluation of patients with endogenous subclinical hyperthyroidism and after restoring euthyroidism | Q82891745 |
| | Changes in body composition in women following treatment of overt and subclinical hyperthyroidism | Q83028630 |
| | Subclinical thyroid disease | Q83315660 |
| | The American Thyroid Association/American Association of Clinical Endocrinologists guidelines for hyperthyroidism and other causes of thyrotoxicosis: a European perspective | Q84333605 |
| | Subclinical hyperthyroidism is not associated with progression of cardiac mass and development of left ventricular hypertrophy in middle-aged and older subjects: results from a 5-year follow-up | Q85100850 |
| | Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients | Q86908520 |
| | Screening and treating subclinical thyroid disease: getting past the impasse | Q86975296 |
| | The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study | Q36428409 |
| | The natural history of euthyroid multinodular goitre | Q36723462 |
| | Review: The association of thyroid dysfunction with all-cause and circulatory mortality: is there a causal relationship? | Q36808365 |
| | Evidence-based management of toxic multinodular goiter (Plummer's Disease). | Q37115495 |
| | Thyroid function and the risk of Alzheimer disease: the Framingham Study | Q37223038 |
| | Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. | Q37413422 |
| | 2013 ETA Guideline: Management of Subclinical Hypothyroidism | Q37582449 |
| | Subclinical thyroid dysfunction and functional capacity among elderly. | Q37587984 |
| | How should we treat patients with low serum thyrotropin concentrations? | Q37594855 |
| | Age- and race-based serum thyrotropin reference limits | Q37645674 |
| | Cardiovascular involvement in patients with different causes of hyperthyroidism | Q37768340 |
| | The dilemma of how to manage Graves' hyperthyroidism in patients with associated orbitopathy | Q37824538 |
| | Thyroid nodule guidelines: agreement, disagreement and need for future research | Q37848646 |
| | A critical review and meta-analysis of the association between overt hyperthyroidism and mortality | Q37897062 |
| | Thyrotoxicosis | Q37991056 |
| | Natural history, diagnosis and management of subclinical thyroid dysfunction | Q38032041 |
| | Mechanisms in endocrinology: Heart failure and thyroid dysfunction | Q38041532 |
| | Radioiodine therapy in benign thyroid diseases: effects, side effects, and factors affecting therapeutic outcome | Q38042022 |
| | Relapse following antithyroid drug therapy for Graves' hyperthyroidism. | Q38238890 |
| | Subclinical thyroid dysfunction and the risk of stroke: a systematic review and meta-analysis | Q38245424 |
| | Lower-but-normal serum TSH level is associated with the development or progression of cognitive impairment in elderly: Korean Longitudinal Study on Health and Aging (KLoSHA). | Q38444141 |
| | The Thyroid Epidemiology, Audit, and Research Study (TEARS): morbidity in patients with endogenous subclinical hyperthyroidism. | Q38494383 |
| | The Thyroid Epidemiology, Audit, and Research Study (TEARS): the natural history of endogenous subclinical hyperthyroidism. | Q38499108 |
| | Approach to management of the patient with primary or secondary intrathoracic goiter | Q39809674 |
| | Analysis of 754 cases of antithyroid drug-induced agranulocytosis over 30 years in Japan | Q40139003 |
| | Subclinical hypothyroidism and hyperthyroidism. I. Prevalence and clinical relevance | Q40531506 |
| | The aging thyroid | Q41070758 |
| | Iodine-induced hyperthyroidism: occurrence and epidemiology. | Q41716407 |
| | Control of adrenergic overactivity by beta-blockade improves the quality of life in patients receiving long term suppressive therapy with levothyroxine. | Q42605403 |
| | The excess risk of major osteoporotic fractures in hypothyroidism is driven by cumulative hyperthyroid as opposed to hypothyroid time: an observational register-based time-resolved cohort analysis | Q42695081 |
| | Natural history of subclinical hyperthyroidism in elderly patients with TSH between 0.1 and 0.4 mIU/l: a prospective study | Q43072006 |
| | Older subjects with hyperthyroidism present with a paucity of symptoms and signs: a large cross-sectional study | Q43099279 |
| | Graves' disease and toxic nodular goiter are both associated with increased mortality but differ with respect to the cause of death: a Danish population-based register study | Q43641693 |
| | Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study | Q43745118 |
| | Subclinical hyperthyroidism as a risk factor for atrial fibrillation | Q43783700 |
| | Low serum thyrotropin level and duration of suppression as a predictor of major osteoporotic fractures-the OPENTHYRO register cohort | Q43799910 |
| | Thyroid function in physiological aging and in centenarians: possible relationships with some nutritional markers | Q43848961 |
| | Comparison of mortality in hyperthyroidism during periods of treatment with thionamides and after radioiodine | Q43962972 |
| | Large differences in incidences of overt hyper- and hypothyroidism associated with a small difference in iodine intake: a prospective comparative register-based population survey | Q44168034 |
| | The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism in clinical and heart abnormalities | Q44392890 |
| | Bone Turnover in Overt and Subclinical Hyperthyroidism Due to Autonomous Thyroid Adenoma | Q44480690 |
| | Radioiodine therapy in elderly patients with subclinical hyperthyroidism due to non-voluminous nodular goiter and its effect on bone metabolism | Q44753759 |
| | Subclinical hyperthyroidism in dementia and correlation of the metabolic index in FDG-PET. | Q44823045 |
| | Effects of TSH-suppressive therapy on cardiac morphology and function: beneficial effects of the addition of beta-blockade on diastolic dysfunction. | Q44887807 |
| | Low thyroid-stimulating hormone as an independent risk factor for Alzheimer disease | Q44927343 |
| | Reduced bone mass detected by bone quantitative ultrasonometry and DEXA in pre- and postmenopausal women with endogenous subclinical hyperthyroidism | Q44945131 |
| | Smoke exposure is associated with a lower prevalence of serum thyroid autoantibodies and thyrotropin concentration elevation and a higher prevalence of mild thyrotropin concentration suppression in the third National Health and Nutrition Examination | Q45173624 |
| | An analysis of the natural course of subclinical hyperthyroidism. | Q46032496 |
| | Observations concerning the natural history of subclinical hyperthyroidism | Q46406536 |
| | Natural history of the transition from euthyroidism to overt autoimmune hypo- or hyperthyroidism: a prospective study | Q46548475 |
| | Risk for fracture in women with low serum levels of thyroid-stimulating hormone | Q46921467 |
| | The feasibility of high dose iodine 131 treatment as an alternative to surgery in patients with a very large goiter: effect on thyroid function and size and pulmonary function | Q47255581 |
| | Thyroid hormones, dementia, and atrophy of the medial temporal lobe | Q48569528 |
| | Standardization of a bioassay for thyrotropin receptor stimulating autoantibodies. | Q50622620 |
| | Serum thyrotrophin at baseline predicts the natural course of subclinical hyperthyroidism. | Q51177172 |
| | Is subclinical thyroid dysfunction in the elderly associated with depression or cognitive dysfunction? | Q51911425 |
| | Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. | Q51971083 |
| | Subclinical hyperthyroidism and the risk of cardiovascular events and all-cause mortality: an updated meta-analysis of cohort studies. | Q53098849 |
| | Lack of association between thyroid disorders and Alzheimer's disease in older persons: a cross-sectional observational study in a geriatric outpatient population. | Q53254556 |
| | Hyperthyroidism in pregnancy. | Q54288450 |
| | Low Serum Thyrotropin Concentrations as a Risk Factor for Atrial Fibrillation in Older Persons | Q57073357 |
| | Subclinical and Overt Thyroid Dysfunction and Risk of All-Cause Mortality and Cardiovascular Events: A Large Population Study | Q57260321 |
| | Associations between thyroid function and mortality: the influence of age | Q57307165 |
| | Subclinical Thyroid Dysfunction and the Risk of Heart Failure in Older Persons at High Cardiovascular Risk | Q57530044 |
| | Cardiovascular Events in Thyroid Disease: A Population Based, Prospective Study | Q61793909 |
| | On the Natural History of Plummer???s Disease | Q67028712 |
| | Elderly patients with suppressed serum TSH but normal free thyroid hormone levels usually have mild thyroid overactivity and are at increased risk of developing overt hyperthyroidism | Q68287761 |
| | Pituitary-thyroid hormone economy in healthy aging men: basal indices of thyroid function and thyrotropin responses to constant infusions of thyrotropin releasing hormone | Q70463231 |
| P433 | issue | 3 | |
| P304 | page(s) | 149-163 | |
| P577 | publication date | 2015-08-26 | |
| P1433 | published in | European thyroid journal : official journal of the European Thyroid Association | Q26853784 |
| P1476 | title | The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism | |
| P478 | volume | 4 | |